Literature DB >> 11751880

Phosphatidylcholine transfer protein promotes apolipoprotein A-I-mediated lipid efflux in Chinese hamster ovary cells.

Juan M Baez1, Suzanne E Barbour, David E Cohen.   

Abstract

Phosphatidylcholine transfer protein (PC-TP) is a cytosolic protein of unknown function that catalyzes intermembrane transfer of phosphatidylcholines in vitro. Using stably transfected CHO cells, we explored the influence of PC-TP on apolipoprotein A-I- and high density lipoprotein 3 (HDL(3))-mediated lipid efflux. In proportion to its cellular level of expression, PC-TP accelerated apolipoprotein A-I-mediated phospholipid and cholesterol efflux as pre-beta-HDL particles. PC-TP increased rates of efflux of both lipids by >2-fold but did not affect mRNA levels or the activity of ATP-binding cassette A1, a plasma membrane protein that regulates apolipoprotein A-I-mediated lipid efflux. Overexpression of PC-TP was associated with only slight increases in HDL(3)-mediated phospholipid efflux and no changes in cholesterol efflux. In scavenger receptor BI-overexpressing cells, PC-TP expression minimally influenced apolipoprotein A-I- or HDL(3)-mediated lipid efflux. PC-TP did not affect cellular phospholipid compositions, phosphatidylcholine contents, or phosphatidylcholine synthetic rates. These findings suggest that a physiological function of PC-TP is to replenish the plasma membrane with phosphatidylcholines that are removed during pre-beta-HDL particle formation due to the activity of ATP-binding cassette A1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751880     DOI: 10.1074/jbc.M106799200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

2.  A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein.

Authors:  Huei-Ju Pan; Diana S Agate; Benjamin L King; Michele K Wu; Steven L Roderick; Edward H Leiter; David E Cohen
Journal:  FEBS Lett       Date:  2006-10-06       Impact factor: 4.124

3.  Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.

Authors:  Hayley T Nicholls; Jason L Hornick; David E Cohen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-06       Impact factor: 4.052

4.  Decreased lipid efflux and increased susceptibility to cholesterol-induced apoptosis in macrophages lacking phosphatidylcholine transfer protein.

Authors:  Juan M Baez; Ira Tabas; David E Cohen
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 5.  Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2.

Authors:  Keishi Kanno; Michele K Wu; Erez F Scapa; Steven L Roderick; David E Cohen
Journal:  Biochim Biophys Acta       Date:  2007-04-12

6.  Trait correlated expression combined with eQTL and ASE analyses identified novel candidate genes affecting intramuscular fat.

Authors:  Yan Liu; Huan Long; Simin Feng; Tingting Ma; Mufeng Wang; Lizhu Niu; Xinyi Zhang; Lianni Wang; Yu Lei; Yilong Chen; Qiankun Wang; Xuewen Xu
Journal:  BMC Genomics       Date:  2021-11-08       Impact factor: 3.969

7.  Novel associations of nonstructural Loci with paraoxonase activity.

Authors:  Ellen E Quillen; David L Rainwater; Thomas D Dyer; Melanie A Carless; Joanne E Curran; Matthew P Johnson; Harald H H Göring; Shelley A Cole; Sue Rutherford; Jean W Maccluer; Eric K Moses; John Blangero; Laura Almasy; Michael C Mahaney
Journal:  J Lipids       Date:  2012-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.